DOI:
10.1055/s-00000022
Das Gesundheitswesen
LinksClose Window
References
Polster M et al.
A comparison of preferences for two GLP-1 products – liraglutide and exenatide – for the treatment of type 2 diabetes.
J Med Econ 2010;
13: 655-661
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.